36
Participants
Start Date
September 30, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
zileuton
Single injection of zileuton 150 mg
placebo
Single injection of placebo
zileuton
Single injection of zileuton 300 mg
Lead Sponsor
Critical Therapeutics
INDUSTRY